Relevant bibliographies by topics / Cardiovascular Diseases – therapy

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Cardiovascular Diseases – therapy'

Author: Grafiati
Published: 4 June 2021
Last updated: 19 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cardiovascular Diseases – therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cardiovascular Diseases – therapy"

1

Topolyanskaya, Topolyanskaya S. V. "Hyperuricemia and cardiovascular diseases." Therapy 7_2020 (October 26, 2020): 71–82. http://dx.doi.org/10.18565/therapy.2020.7.71-82.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Roytberg, Roytberg G. E., Slastnikova I. D. Slastnikova, and Davydova A. Sh Davydova. "Coronary artery calcium: prognostic value for cardiovascular and non-cardiovascular diseases." Therapy 6_2021 (August 23, 2021): 81–90. http://dx.doi.org/10.18565/therapy.2021.6.81-90.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Eliseev, Eliseev M. S. "Cardiovascular diseases in gout and urate-lowering therapy." Therapy 1_2021 (February 19, 2021): 108–15. http://dx.doi.org/10.18565/therapy.2021.1.108-115.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gruchala, Marcin, Himadri Roy, Shalini Bhardwaj, and Seppo Yla-Herttuala. "Gene Therapy for Cardiovascular Diseases." Current Pharmaceutical Design 10, no. 4 (2004): 407–23. http://dx.doi.org/10.2174/1381612043453379.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tamirisa, Kamala, and Debabrata Mukherjee. "Gene Therapy in Cardiovascular Diseases." Current Gene Therapy 2, no. 4 (2002): 427–35. http://dx.doi.org/10.2174/1566523023347643.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tateno, Kaoru, Tohru Minamino, Junji Moriya, et al. "Cell Therapy for Cardiovascular Diseases." Annals of Vascular Diseases 1, no. 2 (2008): 66–79. http://dx.doi.org/10.3400/avd.avdsr00108.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Phillips, M., Jessica Costales, Robert Lee, Edilamar Oliveira, and Andrew Burns. "Antisense Therapy for Cardiovascular Diseases." Current Pharmaceutical Design 21, no. 30 (2015): 4417–26. http://dx.doi.org/10.2174/1381612821666150803150402.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mattson, Craig N. "Drug Therapy in Cardiovascular Diseases." Mayo Clinic Proceedings 61, no. 11 (1986): 919. http://dx.doi.org/10.1016/s0025-6196(12)62625-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

NABEL, E. "Gene therapy for cardiovascular diseases." Journal of Nuclear Cardiology 6, no. 1 (1999): 69–75. http://dx.doi.org/10.1016/s1071-3581(99)90066-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

BAUTERS, C. "Gene therapy for cardiovascular diseases." European Heart Journal 16, no. 9 (1995): 1166–68. http://dx.doi.org/10.1093/oxfordjournals.eurheartj.a061070.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Cardiovascular Diseases – therapy"

1

Mazlan-Kepli, Wardati. "Antiplatelet therapy and clinical outcomes in cardiovascular diseases." Thesis, University of Glasgow, 2016. http://theses.gla.ac.uk/7831/.

Full text
Abstract:
Cardiovascular diseases (CVD) is a leading cause of death in the world. Despite effective treatment regimens for ischaemic heart disease (IHD) and ischaemic stroke, mortality and recurrence rates remain high. Antiplatelet therapy is on effective treatment and reduces the risk of recurrent heart attack and stroke. Nevertheless, there are patients who stopped or interrupted their antiplatelet therapy for certain reasons or some patients may be resistant or poor responders to antiplatelet therapy. Furthermore, there is evidence of rebound effect in platelet activity after antiplatelet cessation a
APA, Harvard, Vancouver, ISO, and other styles
2

DiPeri, Timothy P. "Neuromodulation Therapy Mitigates Heart Failure Induced Hippocampal Damage." Digital Commons @ East Tennessee State University, 2014. https://dc.etsu.edu/honors/208.

Full text
Abstract:
Cardiovascular disease (CVD) is the leading cause of death in the United States. Nearly half of the people diagnosed with heart failure (HF) die within 5 years of diagnosis. Brain abnormalities secondary to CVD have been observed in many discrete regions, including the hippocampus. Nearly 25% of patients with CVD also have major depressive disorder (MDD), and hippocampal dysfunction is a characteristic of both diseases. In this study, the hippocampus and an area of the hippocampal formation, the dentate gyrus (DG), were studied in a canine model of HF. Using this canine HF model previously, we
APA, Harvard, Vancouver, ISO, and other styles
3

Loke, Wai Mun. "Cardiovascular protective effects of dietary polyphenols." University of Western Australia. School of Biomedical and Chemical Sciences, 2008. http://theses.library.uwa.edu.au/adt-WU2009.0051.

Full text
Abstract:
Polyphenols are naturally-occurring phytochemicals, which form an integral part of the human diet. Results from epidemiological studies have associated polyphenol intake with reduced risk of cardiovascular diseases. Previous human intervention studies suggested that dietary polyphenols exert their cardioprotective effects through their antioxidant and anti-inflammatory effects. While most in vitro experiments have not accounted for the bioavailability and metabolism of these polyphenols, our work has provided direct evidence, using quercetin, that metabolic transformation, together with bioava
APA, Harvard, Vancouver, ISO, and other styles
4

Cheung, K. K. "Application of stem cell therapy and magnetic resonance imaging in experimental models of cardiovascular diseases." Thesis, University College London (University of London), 2010. http://discovery.ucl.ac.uk/19292/.

Full text
Abstract:
The incidence of cardiovascular diseases has continued to rise despite better understanding of their pathogenesis, and while mortality is declining with advances in treatment, morbidity has increased dramatically due to the chronic complications of surviving the initial event. In contrast to existing interventions, which primarily aim at limiting tissue damage, stem cell therapy has recently emerged as a novel interventional paradigm where damaged myocardial and other vascular tissues can be regenerated and repaired through transplantation of these primitive cells. This Thesis describes a numb
APA, Harvard, Vancouver, ISO, and other styles
5

Pripp, Ulla. "The effect of sex hormones on hemostasis and cardiovascular riskfactors in postmenopausal women /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7349-982-X/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Karjalainen, A. (Anna). "Effect of estrogen replacement therapy on metabolic risk factors for cardiovascular diseases in hysterectomized postmenopausal women." Doctoral thesis, University of Oulu, 2003. http://urn.fi/urn:isbn:9514272404.

Full text
Abstract:
Abstract Estrogen replacement therapy (ERT) has been associated with favorable effects on risk factors for atherosclerosis. In observational studies ERT was also suggested to reduce the risk of cardiovascular disease in postmenopausal women, but the cardioprotective role of estrogen has been challenged after negative results in randomized trials. However, the mechanisms of estrogen action in atherosclerosis development are only partially known. In order to investigate the regulation of plasma low-density lipoprotein (LDL) cholesterol in postmenopausal women and the effects of ERT on choleste
APA, Harvard, Vancouver, ISO, and other styles
7

Ng, Fook-hong, and 吳福康. "Management of adverse gastrointestinal events in patients with anti-platelet therapy." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B41290963.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ting, Kuei-fu Lily. "Postmenopausal hormone replacement therapy and its effects on lipoprotein metabolism, oxidation and bone related biochemcialvariables." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2000. http://hub.hku.hk/bib/B31241062.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Shi, Jun. "Constructing FHNNs to detect CVDs through hemodynamic parameters derived from sphygmogram." Thesis, University of Macau, 2011. http://umaclib3.umac.mo/record=b2493321.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Shultz, Jennifer M. "Effects of sex steroids and diet on adipose distribution and cardiovascular disease risk factors /." Thesis, Connect to this title online; UW restricted, 2002. http://hdl.handle.net/1773/6592.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Cardiovascular Diseases – therapy"

1

Drug therapy in cardiovascular diseases. Lea & Febiger, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1943-, Hillis W. Stewart, ed. Cardiovascular disease. Springer-Verlag, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Grines, Cindy, and Mark Freed. Essentials of cardiovascular therapy, 1994. Physicians' Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Marsh, Michael S. Hormone replacement therapy and cardiovascular disease. Dunitz, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Antithrombotic drug therapy in cardiovascular disease. Springer, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Schneeweiss, Adam. Cardiovascular drug therapy: Nitrate therapy. Springer-Verlag, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

S, Dhalla Naranjan, ed. Pathophysiology of cardiovascular diseases. Kluwer Academic Publishers, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

M, Rippe James, ed. Manual of cardiovascular diagnosis and therapy. 2nd ed. Little, Brown, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Alpert, Joseph S. Manual of cardiovascular diagnosis and therapy. 4th ed. Little, Brown, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Drug therapy in infants and children with cardiovascular diseases. Lea & Febiger, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Cardiovascular Diseases – therapy"

1

Perin, Emerson C., GuiL’Herme V. Silva, and James T. Willerson. "Stem Cell Therapy for Cardiac Diseases." In Cardiovascular Medicine. Springer London, 2007. http://dx.doi.org/10.1007/978-1-84628-715-2_135.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Watanabe, Yoshimasa, and Donald D. Heistad. "Gene Therapy for Celebral Arterial Diseases." In Cardiovascular Genomics. Humana Press, 2005. http://dx.doi.org/10.1385/1-59259-883-8:285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jain, Kewal K. "Personalized Therapy of Cardiovascular Diseases." In Textbook of Personalized Medicine. Springer New York, 2009. http://dx.doi.org/10.1007/978-1-4419-0769-1_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jain, K. K. "HBO Therapy in Cardiovascular Diseases." In Textbook of Hyperbaric Medicine. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-47140-2_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Muller, David W. M. "Gene Therapy for Cardiovascular Diseases." In Contemporary Concepts in Cardiology. Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-5007-5_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sousonis, Vasileios, Konstantinos Malliaras, John Terrovitis, and John Nanas. "Cell Therapy in Cardiac Diseases." In Introduction to Translational Cardiovascular Research. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-08798-6_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Puddu, P., and M. Muscari. "Therapy versus prevention of coronary heart disease." In Atherosclerosis and Cardiovascular Diseases. Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3205-0_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lalonde, Guy. "Hormone Replacement Therapy and Cardiovascular Diseases." In Clinical Perspectives in Obstetrics and Gynecology. Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4612-4330-4_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Barani, Bahar, Sheeja Rajasingh, and Johnson Rajasingh. "Exosomes: Outlook for Future Cell-Free Cardiovascular Disease Therapy." In Exosomes in Cardiovascular Diseases. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4397-0_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hoang, Giang, Kiet Nguyen, and Anne Le. "Metabolic Intersection of Cancer and Cardiovascular Diseases: Opportunities for Cancer Therapy." In The Heterogeneity of Cancer Metabolism. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_18.

Full text
Abstract:
AbstractAccording to data from the World Health Organization, cardiovascular diseases and cancer are the two leading causes of mortality in the world [1]. Despite the immense effort to study these diseases and the constant innovation in treatment modalities, the number of deaths associated with cardiovascular diseases and cancer is predicted to increase in the coming decades [1]. From 2008 to 2030, due to population growth and population aging in many parts of the world, the number of deaths caused by cancer globally is projected to increase by 45%, corresponding to an annual increase of around four million people [1]. For cardiovascular diseases, this number is six million people [1]. In the United States, treatments for these two diseases are among the most costly and result in a disproportionate impact on low- and middleincome people. As the fight against these fatal diseases continues, it is crucial that we continue our investigation and broaden our understanding of cancer and cardiovascular diseases to innovate our prognostic and treatment approaches. Even though cardiovascular diseases and cancer are usually studied independently [2–12], there are some striking overlaps between their metabolic behaviors and therapeutic targets, suggesting the potential application of cardiovascular disease treatments for cancer therapy. More specifically, both cancer and many cardiovascular diseases have an upregulated glutaminolysis pathway, resulting in low glutamine and high glutamate circulating levels. Similar treatment modalities, such as glutaminase (GLS) inhibition and glutamine supplementation, have been identified to target glutamine metabolism in both cancer and some cardiovascular diseases. Studies have also found similarities in lipid metabolism, specifically fatty acid oxidation (FAO) and synthesis. Pharmacological inhibition of FAO and fatty acid synthesis have proven effective against many cancer types as well as specific cardiovascular conditions. Many of these treatments have been tested in clinical trials, and some have been medically prescribed to patients to treat certain diseases, such as angina pectoris [13, 14]. Other metabolic pathways, such as tryptophan catabolism and pyruvate metabolism, were also dysregulated in both diseases, making them promising treatment targets. Understanding the overlapping traits exhibited by both cancer metabolism and cardiovascular disease metabolism can give us a more holistic view of how important metabolic dysregulation is in the progression of diseases. Using established links between these illnesses, researchers can take advantage of the discoveries from one field and potentially apply them to the other. In this chapter, we highlight some promising therapeutic discoveries that can support our fight against cancer, based on common metabolic traits displayed in both cancer and cardiovascular diseases.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cardiovascular Diseases – therapy"

1

Chtchoupak, Oleg S., Boris N. Shpilevoj, and Natlia L. Zapaeva. "Laser-based optoelectronic system for therapy by medical treatment of cardiovascular diseases." In BiOS Europe '95, edited by Stefan Andersson-Engels, Mario Corti, Ivan Kertesz, et al. SPIE, 1996. http://dx.doi.org/10.1117/12.229526.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chtchoupak, Oleg S., Boris N. Spilevoi, and Natlia L. Zapaeva. "Laser-based optoelectronic system for therapy by medical treatment of cardiovascular diseases." In Photonics West '96, edited by Kurt J. Linden and Prasad R. Akkapeddi. SPIE, 1996. http://dx.doi.org/10.1117/12.237643.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Liang, Fuyou, Shu Takagi, and Hao Liu. "0–1-D Multi-Scale Modeling and Numerical Simulation of the Human Cardiovascular System." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206437.

Full text
Abstract:
Arterial pulse has been recognized from antiquity as the most fundamental sign of life. In clinical practice, cardiovascular diseases are often diagnosed and the effects of therapy monitored and evaluated on the basis of interpretation of arterial pulse characteristics. However, the precise components of arterial pulse that best predict the risk of cardiovascular diseases yet remain a subject of considerable debate.
APA, Harvard, Vancouver, ISO, and other styles
4

Mojarrad, Mehran. "Nanotechnology Based Cancer Therapies." In ASME 2007 2nd Frontiers in Biomedical Devices Conference. ASMEDC, 2007. http://dx.doi.org/10.1115/biomed2007-38034.

Full text
Abstract:
By all accounts cancer remains the leading cause of death for humans of age less than 85 years old. This is partly because of the fact that there has been success in addressing other competing diseases such as cardiovascular leading to an overall drop in the rate of such disease where as after four decades of research success in cancer therapy remains limited. This places a greater demand on developing new therapies to treat cancer. With recent advances in nanotechnology field as applied in medicine there are new opportunities to detect, more effectively target and treat cancer and monitor the
APA, Harvard, Vancouver, ISO, and other styles
5

Prokesova, Radka. "SELECTED ASPECTS OF FINANCIAL AMOUNTS SPENT BY THE CITIZENS OF THE CZECH REPUBLIC ON THE THERAPY OF CARDIOVASCULAR DISEASES." In 4th International Multidisciplinary Scientific Conference on Social Sciences and Arts SGEM2017. Stef92 Technology, 2017. http://dx.doi.org/10.5593/sgemsocial2017/hb11/s03.093.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wingate, Kathryn, Yan Tan, and Wei Tan. "The Effects of Mechanical and Chemical Stimuli on Mesenchymal Stem Cell Vascular Trans-Differentiation and Paracrine Signaling." In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14742.

Full text
Abstract:
Mesenchymal Stem Cells (MSCs) show great promise for the treatment of cardiovascular diseases by tissue engineering and cell therapy. MSCs are particularly useful for vascular therapies as they are easily obtainable, allogenic, trans-differentiate into specific vascular cells, and assist in regenerating vascular tissue through paracrine signaling. [1] However, the mechanisms which direct MSC trans-differentiation and paracrine signaling are not well defined. [2] Incorrect differentiation of MSC can lead to catastrophic side effects such as the development of a dysfunctional endothelium. [3] To
APA, Harvard, Vancouver, ISO, and other styles
7

Patuwondatu, Martini Heniastaty, and icilya Candi. "Effects of Foot Reflexology Massage on Reducing Blood Pressure in Elderly with Hypertension at Sekupang Public Health Center, Batam." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.05.21.

Full text
Abstract:
ABSTRACT Background: Hypertension is significantly associated with increased morbidity and mortality of cerebrovascular diseases, myocardial infarction, congestive heart failure and renal insufficiency. Hypertension is a major public health problem and an important research area due to its high prevalence and a major risk factor for cardiovascular disease and other complications. This study aimed to determine the effect of foot reflexology therapy on lowering blood pressure in elderly people suffering from hypertension in the working area of Sekupang community health center, Batam City. Subjec
APA, Harvard, Vancouver, ISO, and other styles
8

Dahmen, Christian, Tim Wortmann, and Sergej Fatikow. "Magnetic Resonance Imaging of Magnetic Particles for Targeted Drug Delivery." In ASME 2010 First Global Congress on NanoEngineering for Medicine and Biology. ASMEDC, 2010. http://dx.doi.org/10.1115/nemb2010-13149.

Full text
Abstract:
Recently there have been initial investigations towards magnetic resonance imaging (MRI) guided actuation and control of untethered devices inside the human cardiovascular system. This form of therapy has the potential to revolutionize today’s treatment of cancer and other diseases by providing an accuracy of targeted drug application far beyond conventional approaches. Additionally it is based on standard MRI hardware and does not require any special or tailored hardware. In this article, we present recent work that is focused on visual feedback for the position control of untethered magnetic
APA, Harvard, Vancouver, ISO, and other styles
9

Moussa, Heba Adel Mohamed Lotfy, Gawaher Saleh Abbas Mahgoub, Mashael Ali H. I. Al-Badr, and Huseyin Cagatay Yalcin. "Investigating the Cardiac Effects of Sildenafil loaded Nanoparticles on Heart Failure using the Zebrafish Embryo Model." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0217.

Full text
Abstract:
Background: Cardiovascular diseases (CVDs) are the first cause of death worldwide. Vasolidator agents are used to relax cardiac muscle, but their extremely short half-lifes limit their effectiveness. Sildenafil is such an agent used to relax the blood vessels muscles and increase the blood flow. The conventional drug can lead to serious problems in patients duo to the systematic drug delivery. Use of Nanomedicine potentially can enhance delivery of this agent while reducing the systematic effect of the drug. Aim: The purpose of the research is to examine the effectiveness sildenafil loaded nan
APA, Harvard, Vancouver, ISO, and other styles
10

Rindge, David. "Laser therapy in cardiovascular disease." In SPIE BiOS: Biomedical Optics, edited by Nikiforos Kollias, Bernard Choi, Haishan Zeng, et al. SPIE, 2009. http://dx.doi.org/10.1117/12.808050.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Cardiovascular Diseases – therapy' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography